Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Methimazole | 60-56-0 | sc-205747 sc-205747A | 10 g 25 g | $69.00 $110.00 | 4 | |
This antithyroid agent may lead to decreased transcriptional activity of OR51V1 by altering the equilibrium of thyroid hormones that can act on gene expression processes specific to olfactory receptor neurons. | ||||||
Flutamide | 13311-84-7 | sc-204757 sc-204757A sc-204757D sc-204757B sc-204757C | 1 g 5 g 25 g 500 g 1 kg | $46.00 $153.00 $168.00 $515.00 $923.00 | 4 | |
As an antiandrogen, Flutamide could downregulate the expression of OR51V1 if its expression is androgen-dependent, by blocking androgen receptors and reducing the receptor-mediated signaling that promotes gene transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This chemical acts as a DNA methyltransferase inhibitor, potentially leading to the demethylation of the OR51V1 gene promoter region, which could result in the silencing of gene expression if methylation is required for OR51V1 activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Through its action as a histone deacetylase inhibitor, Trichostatin A can cause an increase in acetylated histones, potentially leading to a tightly packed chromatin state around the OR51V1 gene, thereby reducing its transcription. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine′s ability to disrupt lysosomal function could lead to the accumulation of misfolded OR51V1 proteins within the cell, triggering cellular mechanisms that target the mRNA for degradation and thus decrease protein levels. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
By inhibiting the transport of proteins from the endoplasmic reticulum to the Golgi apparatus, Brefeldin A could prevent the proper processing and trafficking of OR51V1, leading to its degradation within the cell and reduced expression at the cell surface. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
This compound halts protein synthesis by interfering with the translocation step in protein elongation, which would result in a direct decrease in OR51V1 protein production, effectively reducing its expression post-transcriptionally. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
This antibiotic binds to DNA and prevents the elongation phase of RNA synthesis by RNA polymerase, which would lead to a decrease in OR51V1 mRNA synthesis and subsequent protein expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
By specifically inhibiting the mTOR signaling pathway, Rapamycin can lead to a downregulation of cap-dependent translation, potentially decreasing the synthesis of proteins such as OR51V1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
This compound is a selective inhibitor of MEK, which could result in the downregulation of OR51V1 by inhibiting the phosphorylation of downstream targets involved in the transcriptional activation of olfactory receptor genes. |